Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies

Background: Methylene blue has a long history of clinical application. Thanks to phenothiazine chromophore, it has potential in photodynamic anticancer therapy. In spite of the growing body of literature that has evaluated the action of this dye on different types of cancer, the systematic understan...

Full description

Bibliographic Details
Main Authors: Amir Taldaev, Roman Terekhov, Ilya Nikitin, Elizaveta Melnik, Vera Kuzina, Mikhail Klochko, Igor Reshetov, Artem Shiryaev, Victor Loschenov, Galina Ramenskaya
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
methylene blue
cancer
tumor
photodynamic therapy
nanopharmaceutics
systematic review
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1264961/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1264961/full

Similar Items